High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T‐cell therapy for large B‐cell lymphoma

RT @mariana_guarana: Very interesting study about #infection in #cart Active #ICANS + steroids 🟰⬆️risk of severe infection ⬆️mortality…

Very interesting study about #infection in #cart Active #ICANS + steroids 🟰⬆️risk of severe infection ⬆️mortality Be aware of “cold sepsis” - as always…let’s not wait for fever! Clinical presentation + risk factors are the most important. https://t.co

Open Access UCL Research: High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma https://t.co/bpKw8nw3R9

RT @Hemasphere_EHA: Infection has emerged as a chief cause of NRM post CAR-T therapy. In this study authors explore severe & life-threateni…